FeesSafety
Pluang+

National Health Investors reveals $272M in signed investment deals and $285M in potential projects.

Market News
14 Sep 2026, 23:05 WIB
PRNewsWire
View Source
Bullish
National Health Investors reveals $272M in signed investment deals and $285M in potential projects.

National Health Investors, Inc. announced it has $272 million in signed Letters of Intent and $51.7 million in real estate purchase options, mainly for senior housing properties. The company plans to use proceeds from a Section 1031 exchange related to a prior portfolio sale to fund these investments, which could defer taxable gains. Additionally, it is evaluating about $285 million in further investment opportunities including sale-leasebacks and loans. These developments signal ongoing growth and strategic investment in senior housing and medical real estate sectors.

National Health Investors, Inc. is advancing with $272 million in signed Letters of Intent and $51.7 million in real estate purchase options. For readers following real estate stocks, here is Pluang's market snapshot as of Sep 15, 2026 02:12 WIB: of 22 priced Real Estate-sector US stocks, 11 rose and 11 fell. Notable movers include VICI Properties Inc at USD 25.08 (+1.01%), Jones Lang LaSalle Inc at USD 343.55 (-0.99%), and Innovative Industrial Properties Inc at USD 56.78 (+0.94%).

More News

Gorilla Technology posts record $69.5M Q3 revenue, targets $200M in 2026 amid AI infrastructure growth

Gorilla Technology posts record $69.5M Q3 revenue, targets $200M in 2026 amid AI infrastructure growth

Gorilla Technology reported a record $69.5 million in revenue for Q3 2026, driven by expanding AI infrastructure projects and hardware deliveries. The company reduced unbilled contract assets by over 50%, improving liquidity as it shifts focus from s...

Company Fundamentals
Bullish
28 minutes ago
Berkshire Hathaway holds steady on Apple shares despite 29% price rise and high valuation in 2026.

Berkshire Hathaway holds steady on Apple shares despite 29% price rise and high valuation in 2026.

Berkshire Hathaway has not sold any Apple shares in 2026, even as Apple's stock price rose 29% and its price-to-earnings ratio neared 40, indicating less concern about valuation. This decision reflects confidence in Apple's strong business fundamenta...

Market News
Bullish
32 minutes ago
US invests $1.6B to build domestic rare-earth supply chain with USA Rare Earth leading Texas mine development.

US invests $1.6B to build domestic rare-earth supply chain with USA Rare Earth leading Texas mine development.

The U.S. government is investing $1.6 billion to develop a domestic rare-earth supply chain, aiming to reduce reliance on China. USA Rare Earth is a key player, using the funds to build out mining and processing capabilities, including developing the...

Market News
Bullish
37 minutes ago
Alamar Biosciences raises 2026 revenue forecast to $121-$123M, driven by biopharma demand and clinical diagnostics expansion.

Alamar Biosciences raises 2026 revenue forecast to $121-$123M, driven by biopharma demand and clinical diagnostics expansion.

Alamar Biosciences increased its full-year 2026 revenue guidance to $121-$123 million, fueled by strong demand for consumables from biopharmaceutical clients who now represent 49% of Q3 revenue. The company’s NULISA platform was selected by the U.K. ...

Company Fundamentals
Bullish
37 minutes ago
CeriBell raises 2026 revenue forecast to $115-$117M, boosts hospital accounts and gross margin to 90%.

CeriBell raises 2026 revenue forecast to $115-$117M, boosts hospital accounts and gross margin to 90%.

CeriBell updated its full-year 2026 revenue guidance to $115 million to $117 million, driven by increased usage per hospital account and expansion by 35 new hospital accounts. The company improved its gross margin to 90% from 88% last year, supported...

Company Fundamentals
Bullish
37 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App